Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
BMY
$59.71
Bristol-Myers Squibb
$.22
.37%
BMY
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus: $1.48
Revenue: $10.37 Bil
Thursday
Nov 5
7:00 AM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Thursday, August 06, 2020
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
What do you expect when BMY reports earnings?
Beat
Meet
Miss
Where is BMY's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$61.54
$60.88
$60.29
$59.63
Support
$59.04
$58.38
$57.79
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Peers
InterCept
BioMarin Pharmaceutical
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Zoetis
Johnson & Johnson
Ultragenyx Pharmaceutical
Merck & Co.
Catalent
Mylan
Expectations
›
Bristol-Myers Squibb
